GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Other Long-Term Liabilities

Ectin Research AB (XSAT:ECTIN B) Other Long-Term Liabilities : kr-0.03 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Other Long-Term Liabilities?

Ectin Research AB's other long-term liabilities for the quarter that ended in Mar. 2024 was kr-0.03 Mil.

Ectin Research AB's quarterly other long-term liabilities stayed the same from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) but then declined from Dec. 2023 (kr0.00 Mil) to Mar. 2024 (kr-0.03 Mil).

Ectin Research AB's annual other long-term liabilities declined from Aug. 2020 (kr0.00 Mil) to Dec. 2022 (kr-0.00 Mil) but then increased from Dec. 2022 (kr-0.00 Mil) to Dec. 2023 (kr0.00 Mil).


Ectin Research AB Other Long-Term Liabilities Historical Data

The historical data trend for Ectin Research AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Other Long-Term Liabilities Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Other Long-Term Liabilities
- - - -

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ectin Research AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Ectin Research AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines